Vancouver, British Columbia and Rehovot, Israel – June 24, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024. CEO Ilan Sobel is scheduled to […]
Vancouver, British Columbia and Rehovot, Israel – June 21, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD), announced today that its board of directors have approved a private placement of up to 697,350 units at a price of USD $7.17 per unit (approx. CAD $9.82) for gross proceeds of up to
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – June 12, 2024) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the Sidoti Small-Cap Investor Conference, being held June 12-13, 2024. CEO Ilan Sobel is scheduled
VINIA® Subscription Growth Drives 101% Year-over-Year Increase in May Product Sales Orders; Cumulative Customer Reviews Surpass 5,000 Vancouver, British Columbia and Rehovot, Israel – June 6, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD), a company pioneering its patented Botanical Synthesis technology platform, today announced that VINIA®, the first commercialized product
BioHarvest Sciences Announces Record $2 Million Monthly Sales Read More »
VANCOUVER, CANADA, and REHOVOT, ISRAEL, June 3, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) announces the completion of the consolidation (the “Consolidation”) of all of its issued and outstanding common shares (“Common Shares”) on the basis of thirty-five (35) pre-Consolidation Common Shares for every one (1) post-Consolidation Common Share. Immediately upon
BIOHARVEST SCIENCES INC. ANNOUNCES COMPLETION OF CONSOLIDATION Read More »
Q1 2024 Revenue Increased 147% Year-over-Year to US$5.34 Million Exceeding Previous Guidance Management Expects Q2 2024 Revenue in the Range of US$5.7-6.0 Million Vancouver, British Columbia and Rehovot, Israel – May 30, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today reported
BioHarvest Sciences Reports First Quarter 2024 Financial Results Read More »
